Diastereoselectivity of the P2Y 11 nucleotide receptor: Mutational analysis

British Journal of Pharmacology

Volumn 155, Issue 8, 2008, Pages 1250-1255

  Ecke, D ^a   Fischer, B ^b   Reiser, G ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Diastereoselectivity; P2Y 11 receptor mutants; P substituted ATP

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE; ARGININE; GLUTAMINE; PURINERGIC P2Y11 RECEPTOR; CALCIUM; PURINERGIC P2 RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CHIRALITY; DNA SEQUENCE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNOMODULATION; ISOMER; MOLECULAR MODEL; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STEREOCHEMISTRY; STEREOSPECIFICITY; AMINO ACID SUBSTITUTION; CHEMISTRY; FLOW CYTOMETRY; GENETICS; METABOLISM; STEREOISOMERISM; TUMOR CELL LINE;

AMINO ACID SUBSTITUTION; CALCIUM; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, PURINERGIC P2; STEREOISOMERISM;

EID: 57349085127     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.352     Document Type: Article

References (21)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C et al. (2006). International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC) 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2): S1-S209.
3. 11. Eur Heart J 28: 13-18.
4. Communi D, Govaerts C, Parmentier M, Boeynaems JM (1997). Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272: 31969-31973.
5. 11 receptor. Br J Pharmacol 128: 1199-1206.
6. 11 receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur J Pharmacol 426: 157-163.
7. Costanzi S, Mamedova L, Gao Z-G, Jacobson KA (2004). Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 47: 5393-5404.
8. 11 nucleotide receptors by adenosine 5′-O-(α-boranotriphosphate) analogues. Br J Pharmacol 149: 416-423.
9. Feng C, Mery AG, Beller EM, Favot C, Boyce JA (2004). Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J Immunol 173: 7539-7547.
10. 6 receptors. J Med Chem 45: 208-218.
11. 1-receptor. J Med Chem 47: 4405-4416.
12. 11 purinergic receptor in human granulocytes. J Biol Chem 281: 31419-31429.
13. 2 receptors. J Med Chem 49: 1980-1990.
14. 1 receptor agonists. J Med Chem 45: 5384-5396.
15. Platts JA, Howard ST, Bracke BRF (1996). Directionality of Hydrogen Bonds to Sulfur and Oxygen. J Am Chem Soc 118: 2726-2733.
16. 11 receptors. Mol Pharmacol 60: 1375-1382.
17. 11 receptor signaling. Blood 102: 613-620.
18. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86: 597-609.
19. 1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor. Biochem Pharmacol 59: 791-800.
20. von Kügelgen I (2006). Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
21. 11 nucleotide receptor deduced from computational modelling and mutational analysis. Biochem J 405: 277-286.